• Publications
  • Influence
The Risk Factors for Discrepancy After Endoscopic Submucosal Dissection of Gastric Category 3 Lesion (Low Grade Dysplasia)
BackgroundTreatment with endoscopic submucosal dissection (ESD) for gastric category 3 lesion (low grade dysplasia, LGD) diagnosed by endoscopic forceps biopsy (EFB) is controversial.AimsThe purposeExpand
  • 32
  • 6
Comparison of Endoscopic Resection Therapies for Rectal Carcinoid Tumor: Endoscopic Submucosal Dissection Versus Endoscopic Mucosal Resection Using Band Ligation
Background: Endoscopic mucosal resection (EMR) has been the endoscopic treatment of choice for rectal carcinoid tumors <10 mm in size. Endoscopic submucosal dissection (ESD) may cause more severeExpand
  • 49
  • 5
Advantage of endoscopic mucosal resection with a cap for rectal neuroendocrine tumors.
AIM To compare the outcomes of endoscopic mucosal resection with a cap (EMR-C) with those of endoscopic submucosal dissection (ESD) for the resection of rectal neuroendocrine tumors. METHODS OneExpand
  • 16
  • 5
Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis.
BACKGROUND Pancreatitis is a major complication of ERCP. OBJECTIVE To determine whether nafamostat mesylate prophylaxis decreases the incidence of post-ERCP pancreatitis (PEP). DESIGN AExpand
  • 51
  • 4
Clinical outcomes of second-look endoscopy after gastric endoscopic submucosal dissection: predictive factors with high risks of bleeding
AbstractBackgroundA second-look endoscopy is routinely performed after endoscopic submucosal dissection (ESD) in many institutions, although the need is questionable. Additional hemostatic proceduresExpand
  • 28
  • 4
Accuracy of high‐frequency catheter‐based endoscopic ultrasonography according to the indications for endoscopic treatment of early gastric cancer
Background and Aim:  The development of endoscopic treatment, such as endoscopic submucosal dissection, extends the indications for endoscopic resection in patients with early gastric cancer (EGC).Expand
  • 50
  • 3
Associated factors for a hyperechogenic pancreas on endoscopic ultrasound.
AIM To identify the associated risk factors for hyperechogenic pancreas (HP) which may be observed on endoscopic ultrasound (EUS) and to assess the relationship between HP and obesity. METHODS FromExpand
  • 36
  • 3
Endoscopic papillary large balloon dilation in Billroth II gastrectomy patients with bile duct stones
Background and Aims:  Patients with Billroth II (B‐II) gastrectomy present technical difficulties during endoscopic stone removal due to altered anatomy. Although endoscopic sphincterotomy alone orExpand
  • 41
  • 2
A Double-Layered (Comvi) Self-Expandable Metal Stent for Malignant Gastroduodenal Obstruction: A Prospective Multicenter Study
BackgroundA self-expandable metal stent (SEMS) has emerged as an effective palliative treatment for malignant gastroduodenal obstruction resulting from gastric or periampullary malignancy. DespiteExpand
  • 32
  • 2
Assessment of disease activity by fecal immunochemical test in ulcerative colitis
AIM To evaluate the efficacy of quantitative fecal immunochemical test (FIT) as biomarker of disease activity in ulcerative colitis (UC). METHODS Between February 2013 and November 2014, a total ofExpand
  • 6
  • 2